Literature DB >> 20969713

Surgery for colonic cancer in HNPCC: total vs segmental colectomy.

D A Stupart1, P A Goldberg, R J Baigrie, U Algar, R Ramesar.   

Abstract

AIM: The high reported risk of metachronous colon cancer (MCC) in hereditary nonpolyposis colorectal cancer (HNPCC) has led some authors to recommend total colectomy (TC) as the preferred operation for primary colon cancer, but this remains controversial. No previous study has compared survival after TC with segmental colectomy (SC) in HNPCC. The aim of this study was to determine the risk of developing MCC in patients with genetically proven HNPCC after SC or TC for cancer, and to compare their long-term survival.
METHOD: This is a prospective cohort study of all patients referred to our unit between 1995 and 2009 with a proven germline mismatch repair gene defect, who had undergone a resection for adenocarcinoma of the colon with curative intent. All patients were offered annual endoscopic surveillance.
RESULTS: Of 60 patients in the study, 39 had TC as their initial surgery and 21 had SC. After 6 years follow up, MCC occurred in eight (21%) SC patients and in none of the TC patients (P = 0.048). The risk of developing MCC after SC was 20% at 5 years. Colorectal cancer-specific survival was better in TC patients (P = 0.048) but overall survival of the two groups was similar (P = 0.29).
CONCLUSION: Patients with HNPCC have a significant risk of MCC after SC. This is eliminated by performing TC as the primary operation for colonic cancer.
© 2011 The Authors. Colorectal Disease © 2011 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2011        PMID: 20969713     DOI: 10.1111/j.1463-1318.2010.02467.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  9 in total

1.  [Open coloproctectomy with ileoanal J-pouch reconstruction].

Authors:  C Isbert; C-T Germer
Journal:  Chirurg       Date:  2014-03       Impact factor: 0.955

2.  Response to letter to editor regarding published article-metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysis.

Authors:  Mark P Lythgoe; Salim S Malik; Mark McPhail; Kevin J Monahan
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

3.  Letter to the editor.

Authors:  C C Anele; A Latchford; O Faiz; S K Clark
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

Review 4.  Cancer risk in Lynch Syndrome.

Authors:  Emma Barrow; James Hill; D Gareth Evans
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

5.  Detection of DNA repair protein in colorectal cancer of patients up to 50 years old can increase the identification of Lynch syndrome?

Authors:  Demétrius Eduardo Germini; Ana Maria Amaral Antônio Mader; Luiz Guilherme Lisboa Gomes; Thérèse Rachel Teodoro; Maria Isete Fares Franco; Jaques Waisberg
Journal:  Tumour Biol       Date:  2015-09-25

6.  Risk of multiple colorectal cancer development depends on age and subgroup in individuals with hereditary predisposition.

Authors:  Lars J Lindberg; Wia Wegen-Haitsma; Steen Ladelund; Lars Smith-Hansen; Christina Therkildsen; Inge Bernstein; Mef Nilbert
Journal:  Fam Cancer       Date:  2019-04       Impact factor: 2.375

7.  Metachronous colorectal cancer following segmental or extended colectomy in Lynch syndrome: a systematic review and meta-analysis.

Authors:  Salim S Malik; Mark P Lythgoe; Mark McPhail; Kevin J Monahan
Journal:  Fam Cancer       Date:  2018-10       Impact factor: 2.375

8.  Total colectomy for multiple metachronous colon cancers in a patient with Lynch syndrome.

Authors:  Masatoshi Kochi; Manabu Shimomura; Takao Hinoi; Hiroaki Niitsu; Takuya Yano; Shoichiro Mukai; Hiroyuki Sawada; Masashi Miguchi; Yasufumi Saito; Tomohiro Adachi; Yasuyo Ishizaki; Hiroyuki Egi; Hideki Ohdan
Journal:  Surg Case Rep       Date:  2015-09-09

9.  Assessing Effectiveness of Colonic and Gynecological Risk Reducing Surgery in Lynch Syndrome Individuals.

Authors:  Nuria Dueñas; Matilde Navarro; Àlex Teulé; Ares Solanes; Mònica Salinas; Sílvia Iglesias; Elisabet Munté; Jordi Ponce; Jordi Guardiola; Esther Kreisler; Elvira Carballas; Marta Cuadrado; Xavier Matias-Guiu; Napoleón de la Ossa; Joan Lop; Conxi Lázaro; Gabriel Capellá; Marta Pineda; Joan Brunet
Journal:  Cancers (Basel)       Date:  2020-11-18       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.